0 Комментарии
0 Поделились
2Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Anal Cancer Drug Market: Chemotherapy, Targeted Therapies, and Immunotherapy Treatment Strategies in Oncology"Executive Summary Anal Cancer Drug Market Research: Share and Size Intelligence The global anal cancer drug market size was valued at USD 401.57 million in 2024 and is projected to reach USD 1,199.82 million by 2032, with a CAGR of 13.80 % during the forecast period of 2025 to 2032. Best-practice models and research methodologies have been employed in the reliable Anal Cancer Drug Market...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Antiemetics Market Growth Addressing Nausea Management Across Oncology and Postoperative CareGlobal Demand Outlook for Executive Summary Antiemetics Market Size and Share CAGR Value The global antiemetics market size was valued at USD 39.68 billion in 2025 and is expected to reach USD 61.87 billion by 2033, at a CAGR of 5.71% during the forecast period The wide-ranging report deals with the new business challenges and investment research on Antiemetics Marketwhich includes...0 Комментарии 0 Поделились 670 Просмотры 0 предпросмотр
-
Asia-Pacific Kirsten Rat Sarcoma (KRAS) Market: Targeted Oncology Therapies, Precision Medicine for Lung and Colorectal Cancer"Future of Executive Summary Asia-Pacific Kirsten Rat Sarcoma (KRAS) Market: Size and Share Dynamics Data Bridge Market Research analyses that the market is growing with a CAGR of 10.4% in the forecast period of 2021 to 2028 and is expected to reach 358.26 million by 2028. The Asia-Pacific Kirsten Rat Sarcoma (KRAS) report encompasses the key developments in the market with respect to...0 Комментарии 0 Поделились 886 Просмотры 0 предпросмотр
-
Carcinoembryonic Antigen (CEA) Market: Cancer Biomarker Testing, Diagnostic Kits, and Monitoring Applications in OncologyExecutive Summary: The Global Carcinoembryonic Antigen (CEA) Market is a vital segment within the cancer diagnostics and tumor marker industry. CEA is a glycoprotein primarily used as a non-specific serum biomarker to monitor treatment efficacy, detect disease recurrence, and provide prognostic information for several cancers, most notably colorectal cancer (CRC). The market is...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Clinical Oncology Next Generation Sequencing Market Market Size, Top Industry Players and Forecast to 2033Clinical Oncology Next Generation Sequencing Industry Outlook: Straits Research has added a report titled “Global Clinical Oncology Next Generation Sequencing Market Professional Report 2025-2033” to its database of research reports. The study provides complete details about the usage and adoption of Clinical Oncology Next Generation Sequencing in various industrial applications...0 Комментарии 0 Поделились 464 Просмотры 0 предпросмотр
-
Global Interventional Oncology Market Trends and Growth ForecastA speciality area of medicine called interventional oncology focuses on using minimally invasive, image-guided techniques to diagnose and treat cancer. It encompasses techniques such as tumor ablation, embolization, and targeted drug delivery, which allow physicians to treat cancerous tissues accurately while minimizing harm to surrounding healthy areas. These approaches offer significant...0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр
-
Gynandroblastoma Market Size, Share, Rare Ovarian Tumor Treatment & Oncology Therapeutic Developments | Industry Forecast to 2029The Gynandroblastoma Market refers to the clinical landscape surrounding the diagnosis, treatment, and supportive care of gynandroblastoma, a rare ovarian tumor featuring both male (Sertoli/Leydig) and female (granulosa) cell components. Although gynandroblastoma accounts for a very small proportion of ovarian neoplasms, specialized diagnostic tools, therapeutic strategies, and...0 Комментарии 0 Поделились 284 Просмотры 0 предпросмотр
-
Hemato Oncology Testing Market Size, Share, Precision Medicine Trends and Strategic Forecast 2032"Executive Summary Hemato Oncology Testing Market Size and Share: Global Industry Snapshot During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.80% , primarily driven by the rising incidence of blood cancers Hemato Oncology Testing Market report offers the most appropriate solution for the business requirements in many ways. To be...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
How Do Oncology Treatment Advances Influence Growth in the Taxane Market?Latest Insights on Executive Summary Taxane Market Share and Size CAGR Value Global taxane market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.6% in the forecast period of 2022 to 2029. The Taxane Market report is the best to know the trends and opportunities in Taxane...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Emerging Trends Influencing the Antibody Drug Conjugates MarketAsia-Pacific is expected to witness rapid growth in the coming years due to increasing healthcare investments and expanding pharmaceutical manufacturing capabilities. Countries like China and India are emerging as important research hubs. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023,...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Future Market Potential of Chemotherapy-Induced Peripheral Neuropathy TreatmentsThe global chemotherapy-induced peripheral neuropathy market size is projected to grow from US$ 1.01 billion in 2025 to approximately US$ 1.67 billion by 2034, reflecting a steady expansion. The market is anticipated to register a compound annual growth rate (CAGR) of around 5.71% during the forecast period, highlighting increasing investments in oncology supportive care. The...0 Комментарии 0 Поделились 929 Просмотры 0 предпросмотр
-
Global CAR-T Cell Therapy Market Growth at 17.5% CAGR Through 2030Increasing research and development activities in cell-based therapies are supporting the expansion of the CAR-T cell therapy market. Pharmaceutical and biotechnology companies are investing heavily in clinical trials and advanced technologies. These efforts are accelerating the development of new and effective cancer treatments. CAR-T Cell Therapy Market to Reach US$ 10.13 Billion by 2030...0 Комментарии 0 Поделились 916 Просмотры 0 предпросмотр
-
Global Liquid Biopsy Market to Reach USD 28.84 Billion by 2033 Driven by Demand for Non-Invasive Cancer DiagnosticsThe global liquid biopsy market size was valued at USD 10.99 billion in 2024 and is projected to reach from USD 12.23 billion in 2025 to USD 28.84 billion by 2033, growing at a CAGR of 11.32% during the forecast period (2025-2033). The growth of the market is attributed to the increasing need for non-invasive procedures to support market growth, the advantages of...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Global Somatostatin Analogs Market Poised for Steady Growth.The global somatostatin analogs market is experiencing robust growth, fueled by the increasing prevalence of hormonal disorders such as acromegaly and neuroendocrine tumors. These synthetic peptides mimic natural somatostatin, a hormone that inhibits the release of several other hormones, thus playing a crucial role in managing complex endocrine conditions. Market Drivers One of the...0 Комментарии 0 Поделились 5Кб Просмотры 0 предпросмотр
-
How Are New Therapies Transforming Treatment in Hodgkin Lymphoma?Global Executive Summary Hodgkin Lymphoma Drug Market: Size, Share, and Forecast CAGR Value Data Bridge Market Research analyses that the Hodgkin lymphoma drug will exhibit a CAGR of around 14.75% for the forecast period of 2022-2029 The global Hodgkin Lymphoma Drug Market analysis report gives a careful overview of the research trends for the financial year. This report studies the...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
Расширенные страницы